A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity
NCT07876518
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Overweight and/or Obesity
Interventions
DRUG:
Placebo
DRUG:
PF-08656795
Sponsor
Pfizer